AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

PENDRAGON PLC

AGM Information Apr 22, 2024

4703_dva_2024-04-22_aff4a92d-a1c7-4325-9d52-195e58654d94.html

AGM Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 5617L

Pinewood Technologies Group PLC

22 April 2024

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

FOR IMMEDIATE RELEASE

22 April 2024

Pinewood Technologies Group PLC ("Pinewood" or the "Company")

Result of General Meeting

The Board of Pinewood is pleased to announce that at the general meeting of the Company held earlier today (the "General Meeting") to consider resolutions to approve the Special Dividend, the Share Consolidation and certain related matters, each of the resolutions were duly passed.

Resolutions 1 and 2 were passed as ordinary resolutions and resolutions 3, 4 and 5 were passed as special resolutions. Full details of the resolutions are set out in Pinewood's explanatory circular to shareholders, dated 5 April 2024 (the "Circular").

The table below sets out the results of the polls at the General Meeting, including the number of votes for and against the resolutions, and the number of votes withheld:

Resolution V otes for % of votes cast Votes against % of votes cast Total votes* % of issued share capital voted Votes withheld
1. To approve the Special Dividend and the Share Consolidation 950,108,999 100.00% 28,200 0.00% 950,137,199 54.53% 0
2. To authorise the directors to allot shares in the Company 949,488,938 99.93% 648,261 0.07% 950,137,199 54.53% 0
3. To authorise the directors to disapply rights of pre-emption when allotting shares in connection with a pre-emptive offer 920,634,558 96.90% 29,487,641 3.10% 950,122,199 54.53% 15,000
4. To authorise the directors to disapply rights of pre-emption when allotting shares in connection with an acquisition or specified capital investment 920,793,901 96.92% 29,288,530 3.08% 950,082,431 54.53% 54,768
5. To authorise the Company to make market purchases of its shares 948,611,645 100.00% 25,054 0.00% 948,636,699 54.45% 1,500,500

*Please note the total votes do not include the votes withheld.

At the voting record time the Company had 1,742,312,440 ordinary shares in issue. The voting rights attached to the ordinary shares are on the basis of one vote per share, representing total voting rights of 1,742,312,440. There are no shares held in treasury.

As part of the Share Consolidation, the Existing Ordinary Shares will be consolidated such that Shareholders will receive 1 New Ordinary Share in substitution for every 20 Existing Ordinary Shares held. Accordingly, it is expected that 87,115,622 ordinary shares of £1.00 each in the capital of the Company will be admitted to trading and dealings will commence on the London Stock Exchange at 8:00 a.m. tomorrow.

In accordance with Listing Rule 9.6.2, the full text of the resolutions passed at the General Meeting has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism. The results will also be made available for viewing on Pinewood's website at https://investor.pinewoodtech.com/.

Capitalised terms used but not otherwise defined in this announcement have the same meaning given to them in the Circular.

Enquiries:

Jefferies International Limited (Financial Adviser and Joint Corporate Broker) +44 (0) 20 7029 8000
Philip Noblet
Thomas Bective
Jordan Cameron
Headland Consultancy (PR & Communications) +44 (0) 20 3805 4822
Henry Wallers
Jack Gault

IMPORTANT NOTICE

Jefferies International Limited ("Jefferies"), which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting solely for the Company, and for no-one else, as broker in connection with the matters referred to in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice to any other person in relation to the content of this announcement or any other matters described in this announcement. To the fullest extent permitted by law, neither Jefferies nor any of its affiliates assumes any responsibility whatsoever for or makes any representation or warranty express or implied, in relation to the contents of this announcement, including its accuracy, completeness or verification or for any other statement made or purported to be made by it, or on its behalf and nothing contained in this announcement is, or shall be, relied upon as a promise or representation in this respect whether as to the past, present or future, in connection with the Company, the Group, or the matters referred to in this announcement. Jefferies and its affiliates accordingly disclaims to the fullest extent permitted by law all and any duty, responsibility and liability whether arising in tort, contract or otherwise which it might otherwise be found to have in respect of this announcement or any such statement or otherwise.

This announcement is not intended to, and does not constitute, or form part of, any offer to sell or an invitation to purchase or subscribe for any securities in any jurisdiction.

This announcement has been prepared for the purpose of complying with the applicable law and regulation of the United Kingdom and information disclosed may not be the same as that which would have been disclosed if this announcement has been prepared in accordance with the laws and regulations of jurisdictions outside the United Kingdom.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ROMZLLFLZZLFBBK

Talk to a Data Expert

Have a question? We'll get back to you promptly.